Branding And Networking Opportunities On Our App!
The global biologic medicines market is projected to exceed USD390 billion by 2020, by which time biologics will account for up to 28% by value of the worldwide market for pharmaceuticals. New biological medicines and other advanced technological production strengthen both Denmark’s and Sweden’s roles as countries to which life science is central.
Increased pressure on prices and the phasing in of a new generation of technology with biological medicines has led to large companies being forced to make cutbacks as well as new investments.
For the past few years, a lot of investment in the biologics industry in the Nordic industry is taking place. For example, AstraZeneca, in 2015, has spent $285m on a new biologics manufacturing facility in Södertälje, Sweden, that it plans to have fully up and running by 2019. The plant will focus on the filling and packaging of protein therapeutics and, from 2018, supplying medicines for the clinical trial programs of AZ and its MedImmune subsidiary. For instance, Norway and Denmark, where physicians have been at the heart of the decision making the process concerning biosimilar medicines, uptake of biosimilar infliximab has been rapid and sustained. These markets demonstrate that trusting and empowering physicians to make the right decisions is a critical component of ensuring the longer-term sustainability of the market.
Biologics World Nordic will be the only focused biologic drugs and vaccines conference in the Nordic region. We will bring together the complete network of the Nordic biologics industry including region’s smaller Biopharma, Big Pharma, International Biopharma, CMOs, CROs, Technocrats & Solution Providers. Partnership opportunities, scientific innovation, manufacturing best practices are at the centre stage waiting to be explored by potential global partners. If Nordic region is important to you, this is where you have to be!
Thomas Jostock Novartis Pharma AG
Dr Hanmant Barkate, MD Glenmark Pharmaceuticals Ltd.
Ralph Knoll AstraZeneca
Jens Kringelum Evaxion Biotech
Soren Bregenholt Macrophage Pharma
Birgette Sogaard Lundbeck
Anders Kronstrom Infant Bacterial Therapeutics AB
Dr Ashesh Kumar Paras Biopharmaceuticals
Rongzan Ho Alvotech
Hooman Hefzi UC San Diego
Florian M. Wurm Swiss Federal Institute of Technology Lausanne (EPFL)
Cleo Kontoravdi Imperial College London
Bjorn Gunnar Voldborg DTU BIOSUSTAIN, Novo Nordisk Foundation Center for Biosustainability
Astrid Durauer University of Natural Resources and Life Sciences Vienna
Dr Rosemary Versteegen International Serum Industry Association
Dr Andreas Herrmann Valerius Biopharma AG
Martin Amark Xbrance Biopharma
Kalveer Flora National Health Service
Mathias Svahn NextCEll Pharma AB
Petter Björquist VERIGRAFT AB
Dr Rasmus Beedholm Medtech Innovation Consortium (MTIC)
Jenny Murray International Serum Industry Association
At Biologics World Nordic 2020, you can be a part of the ONLY conference in the Nordic region targeted at high-level decision-makers from the different Biologics Manufacturers. It dedicates two specific sessions to partnerships and investments in the Nordics Biologics Industry focusing on the regulations particular to the Nordics region
Why should you sponsor?
Biologics World Nordic will provide commercial organizations with the opportunity to educate the market about what to offer. Maximizing face time with key profiles from biologics manufacturers from the Nordics region regulators and national health organizations all in a single location where you can enjoy the option of privately arranged meetings and consultations with selected potential clients.
Be there and be seen!